These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1078607)

  • 1. Partial purification and characterization of a lymphotoxic factor from multiple sclerosis serum.
    White G; Armentrout S; van den Noort S
    Neurology; 1975 Jan; 25(1):37-42. PubMed ID: 1078607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and partial purification of a toxin from Millepora alcicornis.
    Wittle LW; Middlebrook RE; Lane CE
    Toxicon; 1971 Oct; 9(4):327-31. PubMed ID: 4399390
    [No Abstract]   [Full Text] [Related]  

  • 3. Differentiation of antilymphocytic antibodies by analytical ion exchange chromatography: the effect of caprylic acid.
    Hainaut J; Dubarry M; Boffa GA
    Biomedicine; 1974 May; 20(3):223-30. PubMed ID: 4433656
    [No Abstract]   [Full Text] [Related]  

  • 4. Antilymphocyte serum (ALS) as an immunosuppressive agent in transplantation of the canine larynx. II. Purification of antibodies.
    Mogi G; Harvey JE; Ohyama M; Ueda N; Ogura JH
    Laryngoscope; 1972 Feb; 82(2):252-64. PubMed ID: 4622551
    [No Abstract]   [Full Text] [Related]  

  • 5. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Treatment of multiple sclerosis with anti-lymphocyte globulin.
    Seiler FR; Schwick HG
    Lancet; 1975 Apr; 1(7910):806-7. PubMed ID: 48033
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunological aspects in multiple sclerosis. I. Lymphocyte subpopulations and antilymphocyte antibodies].
    Tilbery CP; Lima JG; Scheimberg MA
    Rev Paul Med; 1987; 105(3):134-40. PubMed ID: 3502426
    [No Abstract]   [Full Text] [Related]  

  • 8. [Purification and amino acid composition of the extracellular "alkaline" RNAase of Penicillium chrysogenum 152A].
    Bezborodova SI; Grishchenko VM; Markelova NIu
    Biokhimiia; 1973; 38(2):336-43. PubMed ID: 4781626
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphotoxic activity in multiple sclerosis serum.
    Van den Noort S; Stjernholm RL
    Neurology; 1971 Aug; 21(8):783-93. PubMed ID: 5106294
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphocytotoxic antibody in multiple sclerosis: activity against T cell subsets and correlation with disease activity.
    Scott CF; Spitler LE
    Clin Exp Immunol; 1983 Jul; 53(1):133-9. PubMed ID: 6223730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of human T and B lymphocytes with heterologous antisera. II. Partial characterization of a human T lymphocyte antigen.
    Friedman HP; Brochier J; Revillard JP
    Immunology; 1976 Nov; 31(5):759-65. PubMed ID: 62713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligodendroglial toxicity by serum and lymphocytes from patients with multiple sclerosis.
    Fewster ME; Ellison GW; Myers LW; Kirashige EY
    Neurology; 1975 Aug; 25(8):735-9. PubMed ID: 1080263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocytotoxic and monocytotoxic antibodies in the serum and cerebrospinal fluid of multiple sclerosis patients.
    Rumbach L; Tongio MM; Warter JM; Marescaux C; Mayer S; Rohmer F
    J Neuroimmunol; 1982 Dec; 3(4):263-73. PubMed ID: 6983528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Horse erythrocyte factor enhancing sulphonamide activity. I. Partial purification and data on the mode of action.
    Gláz ET; Machay T
    Folia Microbiol (Praha); 1972; 17(2):88-94. PubMed ID: 4552838
    [No Abstract]   [Full Text] [Related]  

  • 15. [Detection of isoimmune antibodies against a population of human B-lymphocytes].
    Zotikov EA; Tananov AT; Udovichenko AI; Katandzhan NM
    Biull Eksp Biol Med; 1978 Sep; 86(9):324-6. PubMed ID: 308820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cold reactive antilymphocyte antibodies in neurological diseases.
    Lisak RP; Mercado F; Zweiman B
    J Neurol Neurosurg Psychiatry; 1979 Nov; 42(11):1054-7. PubMed ID: 315450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation and purification of antilymphocyte serums].
    Luporini G; Carabelli G; Bazzi C; Galetti G
    Prog Immunobiol Stand; 1970; 4():265-70. PubMed ID: 5482181
    [No Abstract]   [Full Text] [Related]  

  • 18. [Purification and characterization of "Clostridium perfringens" BP6K-N5 strain bacteriocin N5 (author's transl)].
    Wolff A; Ionesco H
    Ann Microbiol (Paris); 1975; 126(3):343-56. PubMed ID: 174471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and immunochemical characterization of human plasma factor XIII.
    Kazama M; McDonagh J; Wagner RH; Langdell RD; McDonagh RP
    Haemostasis; 1976; 5(6):329-40. PubMed ID: 828130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the activity in chicken serum that stimulates the lymphoid development of the embryonic chicken thymus in organ culture.
    Sällström JF
    Acta Pathol Microbiol Scand A; 1974 Sep; 82(5):589-604. PubMed ID: 4415928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.